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Dissection of Hypothalamic-Pituitary-Adrenal Axis
Pathology in 1-Month-Abstinent Alcohol-Dependent
Men, Part 2: Response to Ovine Corticotropin-
Releasing Factor and Naloxone
Bryon Adinoff, Steven R. Krebaum, Patricia A. Chandler, Wen Ye, Morton B. Brown, and Mark J. Williams
Background: Pituitary and adrenal responsiveness is suppressed in abstinent alcohol-dependent indi-
viduals. To clarify the specific organizational disruption in hypothalamic-pituitary-adrenal functioning
during early abstinence, the authors separately assessed each level of the stress-response axis. In this second
of a two-part study, ovine corticotropin-releasing factor (oCRH) was used to stimulate the pituitary
corticotrophs, and naloxone was used to activate the axis at the hypothalamic level. In addition, pulsatile
characteristics of corticotropin and cortisol were assessed over a 12-hr period (0800 to 2000 hr).
Methods: Eleven abstinent alcohol-dependent men and 10 healthy comparison participants were assessed.
All participants were between the ages of 30 and 50 years, and alcohol-dependent patients were abstinent from
4 to 6 weeks. Basal concentrations of corticotropin and cortisol were obtained every 10 min from 0800 to 2000
hr and subjected to pulsatile analysis. Plasma corticotropin and cortisol concentrations were then obtained every
5 to 10 min after low-dose, intravenously administered doses of oCRH (0.4 g/kg) or naloxone (0.125 mg/kg).
Medications were administered at 2000 hr and the two challenge studies were separated by 48 hr.
Results: Pulsatile analysis revealed that the mean corticotropin amplitude was increased in alcohol-
dependent patients relative to controls (p  0.05). Other pulsatile characteristics of corticotropin and all
cortisol pulsatile measures were not significantly different between the two groups. The integrated cortisol
response to oCRH was significantly lower in alcohol-dependent patients compared with controls (p  0.01),
but the integrated corticotropin response was not significantly different. In contrast, neither the cortico-
tropin nor the cortisol response to naloxone was significantly different between groups.
Conclusions: Adrenocorticoid hyposensitivity persists after oCRH infusion for at least 1 month after
cessation of drinking, whereas hyporesponsiveness of the pituitary corticotrophs to CRH seems to resolve
with continued abstinence. The authors suggest that adrenocortical hyporesponsiveness during prolonged
abstinence may impact relapse risk.
Key Words: Adrenal Cortex, Alcoholism, Corticotropin-Releasing Hormone, Naloxone, Pituitary-
Adrenal System.
HYPERCORTISOLEMIA IS EXPERIENCED duringboth chronic alcohol ingestion (Adinoff et al., 2003;
Mendelson and Stein, 1966; Stokes, 1973) and repeated
bouts of alcohol withdrawal (Adinoff et al., 1991; Iran-
manesh et al., 1989; Keedwell et al., 2001). The prolonged
state of glucocorticoid excess in heavy, daily drinkers
(Adinoff et al., 2003; Mendelson and Stein, 1966) seems to
induce pituitary and adrenocortical hyporesponsiveness
that persists after cessation of drinking. Pharmacologic
interventions that restore equilibrium to the hypothalamic-
pituitary-adrenal (HPA) axis may have potential in the
treatment of alcohol dependence. Therefore, isolating the
specific level of axis disruption, the degree of physiological
hyposensitivity at each organ level, and the persistence of
these alterations upon abstinence assumes increasing im-
portance. Such an understanding would allow a targeted,
dose-appropriate pharmacologic intervention upon the
critical axis disruption during a temporally relevant period
of biological vulnerability.
The HPA cascade begins with central activation of hy-
pothalamic corticotropin-releasing hormone (CRH), pri-
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marily in response to fearful or anxiety-inducing stressors.
CRH then induces the synthesis and secretion of cortico-
tropin from the anterior pituitary gland, which in turn
stimulates the production of glucocorticoids from the ad-
renal cortex. The glucocorticoids (primarily cortisol in hu-
mans) have a negative feedback effect on both hypotha-
lamic CRH and pituitary corticotropin secretion.
As noted, the HPA axis exhibits diminished responsive-
ness during early abstinence. For example, cerebrospinal
fluid measures of CRH are reduced in abstinent alcohol-
dependent individuals (Geracioti et al., 1994), suggesting a
decrease in CRH hypothalamic release. In response to
naloxone, which blocks opioid tonic inhibition of CRH
secretion, Inder et al. (1995) observed a blunted cortico-
tropin response in alcohol-dependent men who were 10
days to 6 weeks abstinent. This report suggested a down-
regulation of hypothalamic CRH and/or pituitary cortico-
troph receptors. A number of investigators (Adinoff et al.,
1990; Bardeleben et al., 1989; Costa et al., 1996; Ehrenreich
et al., 1997; Loosen et al., 1991) have reported a similar
blunting of the corticotropin response to ovine
corticotropin-releasing hormone (oCRH), which directly
stimulates pituitary corticotrophs. Adinoff et al. (1990)
demonstrated that the corticotropin suppression seems to
gradually resolve after 3 weeks of abstinence, although
others have shown that this response persists for at least 12
weeks of abstinence (Ehrenreich et al., 1997). The pituitary
corticotropin response has also been shown to be sup-
pressed after nicotine (Coiro and Vescovi, 1999), hyper-
thermia (Vescovi et al., 1997), and insulin-induced hypo-
glycemia (Costa et al., 1996). Downstream adrenocortical
secretion is suppressed after an alcohol challenge (Merry
and Marks, 1972), insulin-induced hypoglycemia (Costa et
al., 1996), operative trauma (Margraf et al., 1967), nicotine
(Coiro and Vescovi, 1999), CRH stimulation (Bailly et al.,
1989), cosyntropin stimulation (Wand and Dobs, 1991),
hyperthermia (Vescovi et al., 1997), cold pressor (Errico et
al., 1993), mental arithmetic (Errico et al., 1993), and pub-
lic speaking (Lovallo et al., 2000) (for review, see Adinoff et
al., 1998).
These cumulative studies implicate a similarly muted
response at each level of the HPA axis for several days, if
not weeks, after cessation of drinking in alcohol-dependent
individuals. The relative consistency of this literature, how-
ever, does not define the relative contribution of each axis
component. Previous studies, for example, have typically
used only a single provocative measure of HPA axis reac-
tivity, limiting concurrent assessments of the hierarchical
levels of HPA axis functioning. Hypothalamic, pituitary,
and adrenal sensitivity to both exogenous and endogenous
stimulation also remains uncertain because high doses of
biological stimuli have typically been used to assess the
system. Such severe activation may produce a ceiling re-
sponse, particularly of the adrenocortical response, thus
masking more subtle disruptions. In addition, the resolu-
tion or persistence of axis disruption with more extended
periods of abstinence remains uncertain. Most studies have
assessed HPA axis functioning in a patient cohort exhibit-
ing varied abstinence intervals, leaving the time frame of
HPA persistence or recovery unanswered. Finally, many
studies of HPA axis responsiveness include patients with
psychiatric and/or other substance use disorders. Because
disruptions in HPA axis alterations have been documented
in other substance use disorders (for review, see Kreek and
Koob, 1998; Sinha, 2001) and psychiatric disorders (Gold
and Chrousos, 2002; Yehuda, 2001), it is critical to separate
out the pathophysiology induced by chronic alcohol inges-
tion as opposed to concomitant disease processes.
In a series of studies, we assessed hypothalamic, pitu-
itary, and adrenal responsiveness in 1-month alcohol-
dependent men. Because of restrictions on the volume of
blood withdrawal and the importance of obtaining all stud-
ies during a similar period of abstinence, two distinct
groups of alcohol-dependent participants were compared
with healthy control participants. In part 1 of the study
(Adinoff et al., 2005), corticotropin and cortisol pulsatile
characteristics were obtained from 2000 to 0800 hr, adre-
nocortical sensitivity was assessed in both the presence and
the relative absence of endogenous pituitary corticotropin,
and the pituitary corticotropin response to dexamethasone
inhibition was obtained. In the current study (part 2), hy-
pothalamic, pituitary, and adrenal activation was assessed
with low doses of both oCRH and naloxone. In addition,
corticotropin and cortisol pulsatility were determined from
0800 to 2000 hr. We hypothesized (1) that the net inte-
grated corticotropin and cortisol responses to oCRH stim-
ulation would be suppressed in the alcohol-dependent
group compared with the healthy controls, indicating de-
creased pituitary responsiveness and (2) that the net inte-
grated corticotropin and cortisol responses to naloxone
stimulation would also be suppressed in the alcohol-
dependent population compared with healthy controls, re-




Eleven male alcohol-dependent participants (aged 43.5  4.8 years;
range, 36–49 years) were recruited from patients requesting treatment for
alcohol dependence at the Dallas VA Medical Center. Eight whites and
three African-Americans participated. Because HPA axis functioning is
altered with increasing age (Anton, 1987; Asnis et al., 1981; Davis et al.,
1984), all participants were aged between 30 and 50 years. Patients re-
ported an alcohol intake of at least 80 g of absolute alcohol (approximately
one six-pack of beer or one half pint of 100% proof distilled spirits) on a
daily basis for at least 2 weeks before the cessation of drinking and had at
least a 10-year history of problematic drinking. To avoid the potential
interaction of other disorders that may also disrupt HPA axis functioning,
patients with a lifetime history of other DSM-IV (American Psychiatric
Association, 1994) axis I psychiatric disorders (such as anxiety, post–
traumatic stress disorder, or mood disorders) not associated with alcohol
use, other substance use disorders within the previous 12 months (exclud-
ing caffeine or nicotine use disorders), medical disorders (i.e., hyperten-
sion, diabetes, chronic pain, or cardiac or pulmonary disorders), or a
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lifetime history of major head trauma were excluded from the study.
Patients reporting at least weekly drug use were also excluded, even in the
absence of a substance abuse or dependence diagnosis. In addition, pa-
tients taking medications that may interfere with HPA axis functioning
(i.e., psychotropics, antihypertensives, hypoglycemic agents) were ex-
cluded. Patients with Beck Depression Inventory (BDI; Beck et al., 1979)
scores above 15 the week before testing were also excluded, as were
patients with alanine aminotransferase (ALT) or aspartate aminotransfer-
ase (AST) 3.0 times greater than the clinical laboratory’s upper limit of
normal.
Healthy Controls
Ten healthy men (aged 38.2  5.4 years; range, 30–47 years), including
eight whites, one Hispanic, and one Asian, were studied. Controls re-
ported no lifetime history of any DSM-IV axis I disorder (except caffeine
or nicotine use disorders), reported no medical disorders, and were taking
no medications. To avoid possible effects of family history of substance
abuse or other psychiatric disorders on HPA axis functioning, controls
with a single first-degree relative or two second-degree relatives with an
axis I disorder were excluded.
Clinical Assessment
All participants underwent a history and physical examination, clinical
laboratory testing (including complete blood count, liver function tests,
routine blood chemistries, thyroid-stimulating hormone test, and HIV
test), electrocardiography, and urine drug screening. Psychiatric and sub-
stance use disorders were assessed using the SCID-Lifetime (First et al.,
1996). Alcohol-dependent patients were detoxified from alcohol on a
locked psychiatric unit using diazepam and were then transferred to a
residential treatment unit. Patients remained in the residential setting
until the studies were initiated between approximately 4 to 5 weeks of
abstinence. To assure abstinence, urine drug screening results were ob-
tained three times weekly and Breathalyzer test results were obtained
whenever the patient left the unit unaccompanied by staff. The study was
approved by the Institutional Review Boards at both the University of
Texas Southwestern Medical Center and the Dallas VA Medical Center.
Informed consent was obtained after the study was fully explained, and
participants were financially compensated for their participation. The
Drinker Inventory of Consequences-Lifetime Consequences (DrInC-2L)
(Miller et al., 1995) was used to assess lifetime severity of alcohol-related
problems. A timeline follow back (Sobell and Sobell, 1978) was used to
assess 1-month, 1-year, and lifetime drinking history.
Neuroendocrine Challenge Tests
Both neuroendocrine studies were performed at the General Clinical
Research Center at the University of Texas Southwestern Medical Center.
Both healthy control and alcohol-dependent participants arrived at the
GCRC at least several hours before the studies. Alcohol-dependent pa-
tients were accompanied to the GCRC from their treatment site.
Pulsatile Characteristics of Corticotropin and Cortisol
Participants were admitted to the GCRC at 1800 hr on day 1. An
intravenous catheter was inserted in each arm at 0700 hr on day 2. Blood
sampling was initiated for pulsatile measures of corticotropin and cortisol
1 hr later (at 0800 hr) and continued through 2000 hr.
Ovine Corticotropin-Releasing Factor Stimulation Test
After the collection of the final basal measure of corticotropin and
cortisol at 2000 hr, 0.4 g/kg oCRH was administered intravenously over
1 min. Blood draws for corticotropin and cortisol were obtained every 5
min from 2000 to 2100 hr and every 10 min from 2100 to 2200 hr.
Intravenous catheters were removed after the 2200 hr blood draws. Cor-
tisol binding globulin (CBG) concentrations were also obtained at 2000 hr,
just before oCRH administration. Alcohol-dependent patients were re-
turned to their treatment site the next morning, and comparison partici-
pants left the GCRC that evening or the next morning. oCRH was
administered at 2000 hr to coincide with the circadian trough to minimize
the effect of basal hormonal concentrations.
Naloxone Stimulation Test
Participants returned to the GCRC by 1700 hr 2 days after the com-
pletion of the oCRH stimulation test. An intravenous catheter was placed
in both arms at approximately 1800 hr on the day of the study. Basal
measures of corticotropin and cortisol were obtained from 1900 to 2000
hr. Naloxone, 0.125 g/kg, was administered intravenously over 1 min
immediately after the 2000 hr blood draw. As described for the oCRH
stimulation test, blood draws for corticotropin and cortisol were then
obtained every 5 min from 2000 to 2100 hr and every 10 min from 2100 to
2200 hr. Intravenous catheters were removed after the 2200 hr blood
draws. One patient did not return to the GCRC for the naloxone stimu-
lation test after completion of the oCRH stimulation test.
Assays
Plasma concentrations of corticotropin were measured by immunora-
diometric assay (IRMA), using reagents from DiaSorin (Stillwater, MN).
This assay has a low-end sensitivity of 1.5 pg/ml, with an intra-assay
coefficient of variation of 2.5–5.4% in the concentration range of 33 to 773
pg/ml. The interassay coefficient of variation is 3.2–5.7% in the concen-
tration range of 8.7 to 257 pg/ml. Serum concentrations of cortisol were
measured by radioimmunoassay (RIA) using reagents from DiaSorin. This
assay has a low-end sensitivity of 0.21 g/dl, with an intra-assay coefficient
of variation of 6.6–7.7% in the concentration range of 2.9 to 47.1 g/dl.
The interassay coefficient of variation is 8.8–9.8% in the concentration
range of 3.7 to 36.9 g/dl. Serum concentrations of CBG were assayed by
RIA using reagents from BioSource Europe S.A. This assay has a low-end
sensitivity of 0.25 g/ml, with an intra-assay coefficient of variation of 3.3
to 7.7 in the concentration range of 33 to 109 g/ml. The interassay
coefficient of variation is 4.5–5.4% in the concentration range of 32 to 105 g/ml.
Statistics
Demographics. Student’s t test (interval data) and 2 contingency table
analyses (nominal data) were used to compare demographic characteris-
tics of the two groups. Items of interest included age, education, employ-
ment status, housing status, marital status, smoking status, and liver
function. Descriptive statistics were used to quantify drinking character-
istics of the alcohol dependent group, including years of problem drinking,
drinking days (previous 30 days and lifetime), standard drinks (previous 30
days and lifetime), and days abstinent at the time of testing. Student’s t test
was used to compare mean scores on the BDI and DrInC-2L.
Basal Corticotropin and Cortisol Pulsatile Characteristics. Because there
is a circadian rhythm for the two hormones of interest, the assumption that
all secretion was pulsatile leads to unreasonably long half-lives for corti-
cotropin and cortisol, resulting in a poor fit of the calculated pulses to the
actual data. Therefore, pulsatile characteristics were assessed by the
Smoothing Baseline Pulse Pulses (SBPP) algorithm (Guo et al., 1999),
which allows for a changing baseline. In general, missing values were not
an issue in these data, but equally spaced observations are required for
analysis in pulse-detection algorithms. Missing values were handled in the
following way. If the concentration at the time point preceding the missing
time point was lower than at the point after the missing time point, the
missing concentration was replaced with the concentration value of the
point preceding the missing time. This was done to avoid creating the
possibility of a pseudopulse. Missing values that were part of a decreasing
trend were linearly interpolated. For various reasons, some series had to
be excluded from the secondary analysis, mainly because they did not show
pulsatility. Pulsatile analysis was completed on seven alcohol-dependent
patients and six controls for corticotropin analyses, and eight patients and
seven controls for the cortisol analyses. Student’s t test was used to
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compare group means. A brief description of the summary measures from
SBPP is given below.
Total probability: The sum of the probabilities of there being a pulse at
each point.
Adjusted input: The sum of input at each time point times the probability
of input at each point. It is a weighted total input.
Number of inputs: The number of input locations with a probability greater
than 0.5. SBPP models the probability of input at each time point, and
we used the 0.5 cutoff to distinguish large input (where input is most
likely occurring) from small input (unlikely) locations. This measure
allows the comparison of input frequencies between the two groups but
is not a measure of pulse number.
Average baseline: The mean of the baseline values estimated at each point.
SBPP allows for a changing baseline, so baseline itself is no longer a
parameter.
Mean amplitude: The net mean height of pulses after subtracting the
changing baseline.
Time  Group Analysis. Repeated-measures ANOVA on the mean
hormone level over four 3-hr blocks (i.e., 0800–1050, 1100–1350, 1400–
1650, and 1700–2000 hr) was performed to incorporate all participants
into the circadian analysis. Because the distribution of data was skewed,
each block mean of both corticotropin and cortisol was log (base-e)
transformed before analysis.
Pharmacologic Challenge Studies. Corticotropin and cortisol secretion
were compared between 2000 and 2200 hr by the area-under-the-curve
method, or net integrated response, and by net peak corticotropin and
cortisol for both the oCRF and the naloxone challenge. Because the net
integrated response was similar to the net peak response, only the former
is reported. The net integrated response was calculated by taking the
average hormone concentration between consecutive measurement
points, multiplying by the time interval between the points, summing
across time, and netting out basal hormone levels multiplied by the total
time interval over which measurement occurred (i.e., 120 min). For each
of these analyses, Student’s t test was used to compare group means.
Missing values (10 total) were estimated based on the mean of hormone
measures taken directly before and after the missing values.
Correlation Analysis. The relation between drinking history (i.e., drinks
in previous 30 days, lifetime drinks) and various neuroendocrine measures
(basal cortisol and corticotropin concentrations before oCRH, integrated
cortisol and corticotropin response after oCRH, and integrated cortisol




The 11 alcohol-dependent patients were more likely to
be unemployed (p  0.02), had fewer years of education (p
 0.001), and were more likely to be smokers (p  0.001)
relative to the healthy controls. Although the alcohol-
dependent patients were a few years older than the controls
(p  0.05), mean ages were less than 5 years apart, and all
participants were between the ages of 30 and 50 years. The
patient group also had higher BDI (p  0.001) scores at the
time of the first study compared with controls. Alcohol-
dependent patients reported an onset of drinking problems
at 17.6  3.0 years (range, 12–23 years) and had been
drinking an average of 23.9  5.4 years (range, 17–34
years). These patients reported drinking 26.9  4.4 days
(range, 19–30 days) in the 30 days before drinking cessation
and drank 637  331 standard drinks (range, 154–1234
standard drinks) of alcohol over that period (one standard
drink  1 oz spirits, 4 oz wine, or 12 oz beer). Alcohol-
dependent patients were abstinent 29.3  3.3 days (range,
24–35 days) at the time of the study. Total DrInC-2L
(Miller et al., 1995) scores in the alcohol-dependent group
(34.1  10.7) were significantly higher (p  0.001) than
those of controls (3.1  2.8). Despite their extensive drink-
ing history, liver enzymes (ALT and AST) were not signif-
icantly different between alcohol-dependent and control
groups, and levels of ALT and AST were not markedly
higher than the clinical laboratory range for healthy indi-
viduals (ALT, 0–40 units/liter; AST, 0–37 units/liter).




(n  10) t or 2 dF p Value
Age (years) 43.45  4.80 38.20  5.4 2.358 19 0.029










Employed 6 10 5.97 1 0.015
Education (years) 12.3  1.7 16.9  2.8 4.52 18 0.000
Homeless 3 0 3.18 1 0.074
Nicotine dependent 10 0 17.35 1 0.000
Beck Depression Score 10.3  7.8 0.7  1.6 3.81 18 0.001
ALT (units/liter) 24.8  18.2 27.7  12.0 0.40 18 NS
AST (units/liter) 21.6  8.5 24.1  6.0 0.74 18 NS
DrInC 34.1  10.7 3.1  2.8 8.45 17 0.000
Years problem drinking 23.9  5.4
Drinks in past 30 days 637  331
Lifetime drinks 146,193  82,485
Data are mean  SD. Comparisons between groups were by t test or 2.
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Secretory Characteristics of Corticotropin and Cortisol
Secretory characteristics were determined by SBPP, an
algorithm to assess pulsatility that allows for a changing
baseline. Corticotropin mean amplitude (net mean height
of pulses after subtracting the changing baseline) was sig-
nificantly (p  0.05) higher in alcohol-dependent (8.5  5.7
pg/ml) compared with healthy control participants (2.9 
1.6 pg/ml). Therefore, corticotropin mean amplitude in the
alcohol-dependent group was almost 3-fold greater than
that of the controls. There was also a trend toward an
increase in the average baseline (the mean of the baseline
value estimated at each point) in the alcohol-dependent
patients relative to the controls (p  0.08). There were no
other significant differences in corticotropin pulsatile char-
acteristics between groups, and there were no differences in
any of the cortisol measures. Time  group ANOVA using
all participants (10 in each group) found that corticotropin
concentrations tended to be higher in alcohol-dependent
patients compared with controls over the 12-hr period
(0800–2000 hr; p  0.10), although the comparisons did not
reach statistical significance. There was no significant
group effect of cortisol concentrations (p  0.072) or a
group  time effect for either hormone. Both corticotropin
and cortisol had a significant within-group time effect (p 
0.0001). (See Table 2 and Fig. 1.)
Ovine Corticotropin-Releasing Factor Stimulation Test
Mean basal corticotropin and cortisol concentrations
(1930 to 2000 hr) were not significantly different be-
tween abstinent alcohol-dependent patients and healthy
controls. CBG concentrations in the alcohol-dependent
and healthy control men were also similar between the
two groups at 2000 hr, as was the calculated free cortisol
index (le Roux et al., 2002; serum cortisol in M/CBG in
M). Alcohol-dependent patients had a significantly
lower integrated cortisol response to oCRH stimulation
compared with healthy controls (p  0.01), whereas the
integrated corticotropin response to oCRH stimulation
was similar in the two groups. The net integrated corti-
cotropin response to net integrated cortisol response
(i.e., the ratio of net integrated corticotropin response/
net integrated cortisol response) was 87% greater in the
alcohol-dependent patients (3.91  2.70) compared with
the controls (2.09  0.96). This finding suggests that for
each unit of corticotropin secreted after oCRH stimula-
tion, controls responded with almost twice as much cor-
tisol as did the patient group. Although this difference
did not reach statistical significance [t(19)  2.01, p 
0.06], the percent increase in net peak corticotropin to
percent increase in net peak cortisol in alcohol-
dependent patients (67.4  22.6%) was significantly in-
creased relative to the controls (51.3  8.4%) [t(19) 
2.20, p  0.05]. (See Table 3 and Fig. 1.)
Naloxone Stimulation Test
As observed before oCRH infusion, mean basal concen-
trations of corticotropin and cortisol (1930 to 2000 hr) were
not significantly different between the alcohol-dependent
and healthy controls before naloxone administration. Mean
basal calculated free cortisol index, using CBG measures
Table 2. Corticotropin and Cortisol Pulsatile Characteristics as Determined by SBPP analysis and mean Corticotropin and Cortisol Concentrations Over 12 hr
(0800–2000 hr) and in 3-hr Blocks
Healthy Controls Alcohol Dependent t stat df p Value
Corticotropin pulsatile characteristics
Total probability 17.1  9.1 11.8  9.3 1.04 11 NS
Adjusted input 50.8  21.1 66.4  50.0 0.7 11 NS
Number of Inputs 13.8  10.6 8.3  7.8 1.09 11 NS
Average baseline 18.5  3.9 29.3  12.9 1.97 11 0.075
Mean amplitude 2.9  1.6 8.5  5.7 2.29 11 0.043
Half-life 21.4  7.1 42.1  28.5 1.72 11 NS
Mean corticotropin concentrations (pg/ml)
0800–2000 hr (total 12 hr) 27.3  8.6 35.4  12.5 1.72 19 NS
0800–1050 hr 29.8  10.2 42.2  16.7 2.03 19 0.057
1100–1350 hr 28.1  9.7 37.3  14.4 1.69 19 NS
1400–1650 hr 28.8  8.3 37.7  14.0 1.75 19 0.096
1700–2000 hr 23.9  7.2 28.3  8.9 1.23 19 NS
Cortisol pulsatile characteristics
Total probabilitya 19.2  7.5 16.3  7.7 0.71 13 NS
Adjusted inputb 35.3  12.3 23.9  10.5 1.9 13 NS
Number of inputsc 16.4  6.1 13.1  7.4 0.9 13 NS
Average baselined 4.4  2.2 4.1  0.7 0.3 13 NS
Mean amplitudee 2.0  1.1 1.7  0.9 0.7 13 NS
Half-life 36.3  16.1 44.3  18.3 0.9 13 NS
Mean cortisol concentrations (g/dl)
0800–2000 hr (total 12 hr) 7.7  1.6 7.3  2.5 0.36 19 NS
0800–1050 hr 10.7  2.2 10.1  3.4 0.48 19 NS
1100–1350 hr 7.9  1.7 7.6  2.8 0.26 19 NS
1400–1650 hr 7.5  1.9 6.9  2.4 0.65 19 NS
1700–2000 hr 5.9  2.0 5.7  2.7 0.13 19 NS
See text for description of SBPP measures.
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obtained before the oCRH infusion, were also not signifi-
cantly different between the two groups. There was not a
significant difference in the net integrated corticotropin or
cortisol response to naloxone stimulation between the two
study groups. There were no significant group differences
in corticotropin response to cortisol response after nalox-
one. (See Table 3 and Fig. 1.)
Correlation Between Neuroendocrine and Clinical Variables
We assessed the relation between relevant neuroendo-
crine measures (e.g., integrated cortisol response to oCRH
and the corticotropin response to cortisol response after
both oCRH and naloxone) and measures of previous drink-
ing history (e.g., number of drinks in 30 days before absti-
nence, 1 year before abstinence, and lifetime drinking).
Fig. 1. Mean  SD of corticotropin (cosyntropin; top) and cortisol (bottom) concentrations. Left panels: Measures between 2000 and 0800 hr reflect basal
concentrations; oCRH (0.4 g/kg iv) was administered at 2000 hr. The integrated cortisol response to oCRH was significantly lower in the alcohol-dependent
participants compared with the healthy controls (p  0.02). Right panels: Naloxone (125 g/kg iv) was administered at 2000, 48 hr after oCRH administration. Closed
circles represent healthy control participants; open circles represent alcohol-dependent participants.
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There were no significant correlations between any of the
plasma hormone responses and drinking variables.
DISCUSSION
Our findings reveal that 1-month-abstinent alcohol-
dependents exhibit (1) an increase in the corticotropin
amplitude and average baseline by SBPP but similar corti-
sol pulsatile characteristics and (2) a significantly blunted
glucocorticoid response after oCRH stimulation in the
presence of an corticotropin response not significantly dif-
ferent from that of the control group. These findings sup-
port a decrease in glucocorticoid responsiveness relative to
corticotropin release in abstinent alcohol-dependent pa-
tients. In contrast, the corticotropin and cortisol responses
to naloxone did not significantly differ between the two
groups.
Alcohol-dependent patients revealed a relative increase
in 0800 to 2000 hr corticotropin amplitude and baseline
concentrations (by SPBB) and mean plasma concentrations
in the presence of cortisol pulsatile characteristic and
plasma concentrations within the control range. In part 1 of
this study (Adinoff et al., 2005), we reported that cortisol
amplitude and mean concentrations were decreased in
alcohol-dependent patients compared with controls from
2000 to 0800 hr, whereas corticotropin measures were sim-
ilar. Both sets of findings suggest a decrease in cortisol
responsiveness relative to corticotropin stimulation. Al-
though two different alcohol-dependent patient samples
were used for parts 1 and 2, these two groups were similar
in age [t(20)  0.34, p  0.74], years of alcohol problems
[t(20)  1.30, p  0.21], drinks over the previous 30 days
[t(19)  1.03, p  0.31], and DrInC scores [t(19)  0.91, p
 0.37]. Six controls were used for both studies (after at
least a 6-week interval between parts 1 and 2). In addition,
the leading and terminal points (0800 and 2000 hr) of the
two 12-hr measures were in relatively close proximity.
Unlike the current study, Adinoff et al. (1991), Iran-
manesh et al. (1989), and Loosen et al. (1991) did not
observe differences in the pulsatile characteristics of corti-
cotropin or cortisol during abstinence in alcohol-dependent
patients compared with controls. The SBPP modeling tech-
nique may have uncovered group differences in cortico-
tropin amplitude not observed by others. The careful se-
lection of our patient population, including the exclusion of
patients with a lifetime history of other psychiatric disor-
ders and/or a recent history of drug dependence and the
specific 1-month time frame of abstinence, may also explain
our findings. However, our patient data showed a fair
amount of variability, and comparisons met only relatively
low levels of statistical significance or trend levels.
Previous studies of the pituitary responsiveness in
alcohol-dependent participants have consistently demon-
strated a diminished response to various physical and psy-
chological stressors. The specific time after abstinence,
however, seems critical in understanding this literature. For
example, Adinoff et al. (1990) assessed corticotropin and
glucocorticoid responsiveness to 1 g/kg oCRH in alcohol-
dependent men at 1 week, 3 weeks, 3 weeks to 6 months,
and more than 6 months of abstinence. A marked suppres-
sion of the corticotropin response was observed at 1 week
of abstinence compared with controls. Alcohol-dependent
participants at 3 weeks of abstinence showed a significant
increase in their corticotropin response compared with 1
week, nevertheless still significantly less than controls. The
group that was abstinent for more than 3 weeks to 6 months
revealed a corticotropin response similar to that of con-
trols. This was similar to the work of Costa et al. (1996),
who showed a blunted corticotropin and cortisol response
to oCRH in 1-week to 2-weeks-abstinent subjects. Other
investigators who showed a blunted corticotropin response
to oCRH or human CRH studied subjects with varied
periods of abstinence (Inder et al., 1995: 10 days to 6 weeks;
Loosen et al., 1993: 15 to 39 days; Bardeleben et al., 1989:
2 to 6 weeks), thus possibly mixing early abstinent (e.g., 3
weeks or fewer) corticotropin-suppressed subjects with
later abstinent (e.g., more than 3 weeks) corticotropin-
normalized subjects. In confirmation, Bailly et al. (1989)
did not describe a blunted corticotropin response in
alcohol-dependent subjects assessed at 4 weeks of absti-
nence, although a blunted cortisol response was observed.
However, the mean abstinent periods in the studies of
Inder et al. (1995) (25  3 days) and Loosen et al. (1993)
(42.9  25.7 days) were similar to ours (29.6  1.0 days),
and Ehrenreich et al. (1997) showed a blunted cortico-
tropin response to oCRH in 12-weeks-abstinent subjects.
Other differences between our study and previous studies
of the HPA axis in alcohol-dependent subjects include our
rigorous exclusion criteria, including any other substance
use disorders in the previous year (other than nicotine) and
a lifetime history of axis I disorders. To our knowledge, the
Table 3. Plasma Basal Concentrations and Stimulated Corticotropin and Cortisol Response to oCRH (0.4 g/kg) and Naloxone (125 g/kg) in 1-Month-Abstinent
Male Alcohol-Dependent Participants and Age-Matched Healthy Controls
oCRH Stimulation Test Naloxone Stimulation Test
Alcohol Dependent Controls t (19) p Alcohol Dependent Controls t (18) p
Basal corticotropin (pg/ml) (1930–2000 hr) 23.0  8.9 18.9  4.5 1.31 NS 21.4  7.8 17.8  4.6 1.26 NS
Basal cortisol (g/dl) (1930–2000 hr) 3.9  2.4 3.6  1.2 0.42 NS 2.4  1.5 3.1  0.7 1.27 NS
Cortisol binding globulin (g/ml) 33.0  7.2 36.3  6.3 1.10 NS 32.6  7.5 36.3  6.3 1.16 NS
Free cortisol index 0.17  0.09 0.14  0.03 1.03 NS 0.11  0.06 0.12  0.03 0.80 NS
Net integrated corticotropin response (pg/ml.2 hr) 2518  1242 2051  801 1.01 NS 878  528 538  392 1.64 NS
Net integrated cortisol response (g/dl.2 hr) 715  261 1027  235 2.86 0.01 346  305 326  271 0.15 NS
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other studies referenced did not incorporate such stringent
diagnostic criteria.
In our study, the absence of a decreased pituitary corti-
cotropin response to oCRH in alcohol-dependent partici-
pants may also be related to the relatively low dose of CRH
administered. The lower dose of CRH was used to avoid a
ceiling glucocorticoid response to oCRH, thus potentially
masking diminished adrenocortical reactivity in the
alcohol-dependent group. Therefore, the current study ad-
ministered an oCRH bolus of 0.4 g/kg, compared with 1.0
g/kg in Adinoff et al. (1990), Costa et al. (1996), Inder et
al. (1995), and Loosen et al. (1993); 100 g in Bardeleben
et al. (1989), and 150 g in Ehrenreich et al. (1997). The
higher oCRH doses initially provoke a larger corticotropin
and cortisol response, presumably inducing a more robust
glucocorticoid inhibitory effect on the pituitary cortico-
trophs and suppressing further corticotropin release. Such
a mechanism of diminished corticotropin responsivity has
been posited in depression (Gold and Chrousos, 2002),
where a heightened adrenal response is thought to quickly
suppress pituitary corticotropin production and release.
We have recently observed that 1-month-abstinent alcohol-
dependent patients exhibit increased corticotropin suppres-
sion after high-dose dexamethasone (Adinoff et al., 2005),
suggesting increased sensitivity of the pituitary glucocorti-
coid receptors. A less robust adrenocorticoid response to
the lower dose of oCRH (0.4 g/kg) in our patient popu-
lation may therefore not have reached levels necessary to
suppress pituitary secretion. In fact, as observed in Fig. 1,
the corticotropin response in alcohol-dependent patients
tended to be greater (not smaller) than in controls. How-
ever, this finding did not reach significance, perhaps be-
cause of the small sample size and substantial variance.
The administration of naloxone also did not induce an
attenuated pituitary response in alcohol-dependent pa-
tients, as previously reported by Inder et al. (1995). Again,
a more variable length of abstinence, a higher dose of
naloxone (20 mg), and/or less restrictive selection criteria
(including the ongoing use of disulfiram in the patient
population) of Inder et al. (1995) may account for these
differences. Although the diminished plasma cortisol re-
sponse to oCRH in alcohol-dependent patients would also
be expected after the naloxone challenge 2 days later, we
did not observe a blunted adrenocorticoid response to
naloxone. It seems that the absence of this finding may
have been due to the somewhat higher corticotropin re-
sponse to naloxone in the alcohol-dependent patients (Fig.
1). However, differences in the corticotropin response did
not reach significance between groups, possibly because of
the small sample size and variance in the data. The height-
ened corticotropin response to naloxone may reflect pre-
morbid differences, as Wand et al. (2001) has reported that
the corticotropin response to naloxone is increased in the
children of alcohol-dependent individuals. Also unexpected
was the absence of a significant correlation between the net
integrated corticotropin response/net integrated cortisol re-
sponse to oCRH relative to the net integrated corticotropin
response/net integrated cortisol response to naloxone (r 
0.25, p  0.289). Although the preceding oCRH stimu-
lation test may have altered the subsequent naloxone stim-
ulation test, the 48-hr intervening interval would be ex-
pected to minimize any carryover effect. Unfortunately, we
did not counterbalance the oCRH and naloxone infusions.
The naloxone and oCRH challenge studies presented
here were accompanied by a series of other basal and
stimulated assessments of HPA axis reactivity in alcohol-
dependent subjects (Adinoff et al., 2005). These studies
revealed significantly attenuated basal mean concentra-
tions and pulsatile amplitude of plasma cortisol from 2000
to 0800 hr, a blunted glucocorticoid response to low-dose
cosyntropin after dexamethasone pretreatment, and a
heightened pituitary response to dexamethasone negative
feedback. In toto and in context with other studies refer-
enced above, these studies suggest the following scenario:
Central activation of the HPA axis by chronic drinking and
repeated withdrawal states induce a prolonged state of
hypercortisolemia. The HPA axis adapts to the persistently
increased plasma cortisol concentrations by down-
regulating the hypothalamic, pituitary, and adrenal re-
sponses. At 4 weeks of abstinence, increased sensitivity of
the pituitary corticotrophs to glucocorticoid negative feed-
back and diminished adrenocortical reactivity persists, ac-
companied by normalization of the hypothalamic and pitu-
itary response to higher-level stimulation.
Our design had several notable strengths. Patients and
controls were similar in age and race. Although ages were
significantly different between the two groups, the mean
ages were within 5 years of each other and were all within
an age range during which HPA axis functioning remains
stable. Neither group had significant medical disorders and
were not taking any psychotropic or other medications that
are known to alter HPA axis functioning. Alcohol-
dependent patients were assessed within a relatively con-
stricted period of abstinence, had no lifetime history of
other non–substance-related psychiatric disorders, had no
other substance use disorders in the previous year or fre-
quent drug use not meeting DSM-IV criteria (except nico-
tine dependence), and reported extensive drinking histo-
ries. Controls had no personal or family history of
substance use disorders (except nicotine) and reported no
lifetime history of other axis I disorders. These findings
may not extend to alcohol-dependent females. In addition,
alcohol-dependent patients were smokers, and controls
were not. However, a previous study has reported that
cigarette smoking in abstinent alcohol-dependent subjects
did not alter the pituitary-adrenal response to a pharma-
cological challenge (Anthenelli et al., 2001).
Raison and Miller (2003) have posited that “hypoadrenal
states” may be due to decreased glucocorticoid bioavail-
ability, attenuated glucocorticoid responsiveness, and/or
accentuated inhibitory feedback on the pituitary cortico-
trophs. Such hypoadrenal states have been observed in
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atypical depression, chronic fatigue, post–traumatic stress
disorder, and fibromyalgia (see reviews in Heim et al.,
2000a; Raison and Miller, 2003) Although the clinical rel-
evance of the hypoadrenal states remains speculative, de-
creased concentrations of glucocorticoids are associated
with early trauma, depressive mood states, dysphoric
arousal, and behavioral dyscontrol and inhibition (Heim et
al., 2000b; King et al., 1990; Tennes and Kreye, 1985;
Vanyukov et al., 1993; Virkkunen, 1985; Yehuda, 2001).
With respect to substance use disorder, glucocorticoid ad-
ministration increases drug intake in animal models (Goe-
ders, 2002; Piazza et al., 1993), possibly through activation
of mesolimbic dopaminergic neurotransmission (Barrot et
al., 2000; Piazza et al., 1996). Conversely, Nash and Maickel
(1988) have demonstrated that the unrestrained increase
(e.g., absence of glucocorticoids) of hypothalamic CRH
and pituitary corticotropin release after stress is causally
related to increased drinking, and the increased drinking
behavior was suppressed by the administration of exoge-
nous glucocorticoids. Human studies demonstrate that in-
hibition of glucocorticoid synthesis in methadone-
maintained patients is associated with the increased use of
cocaine (Kosten et al., 2002), and Kiefer et al. (2002) have
presented preliminary data suggesting a relation between
low basal concentrations of glucocorticoids and early re-
lapse. The positive relation between HPA axis disinhibition
by naltrexone and craving in alcohol-dependent subjects
(O’Malley et al., 2002) suggests that glucocorticoid com-
pensation in abstinent subjects may have therapeutic
relevance.
Our findings offer further evidence for the persistent
attenuation of adrenocortical reactivity in alcohol-
dependent men. The diminished response is also sensitive
to low levels of stimulation and is present for at least 1
month after cessation of drinking. Future studies should
explore whether glucocorticoid hyposensitivity response
persists with even longer periods of abstinence and confirm
whether this disruption in neuroendocrine functioning is
associated with a heightened relapse risk.
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